Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123282) titled 'Clinical Study of Chemogenetic Gene Therapy with AAV virus for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Second Affiliated Hospital of Zhejiang University School of Medicine
Condition:
Parkinson's disease
Intervention:
Low titer group:Intracerebral injection of 1x10^12 VG/mL AAV2/9-hSyn-hM4Di injection solution into the bilateral subthalamic nuclei
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Low titer group:3;High titer ...